Maxitrol eye drops - is a combined ophthalmic preparation with anti-inflammatory, anti-allergic and antibacterial action. The composition of the drug includes two antibiotics and glucocorticosteroid, which provides a wide range of bactericidal effects.
Maxitrol is a combined preparation for topical application in ophthalmology. Glucocorticosteroid + antibiotics (aminoglycoside and cyclic polypeptide).
Neomycin
Has a bactericidal effect, disrupting the synthesis of the bacterial cell protein. It is active against: Staphylococcus aureus, Corynebacterium diphteriae, Streptococcus viridans, Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, Aerobacter aerogenes, Haemophilus influenzae.
Polymyxin
The mechanism of action of polymyxin B is mainly due to blockade of the permeability of the cytoplasmic membrane of bacterial cells. It is active against: Pseudomonas Aeruginosa, Aerobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, Koch-Weeks bacillus.
Dexamethasone
Glucocorticosteroid. Has anti-inflammatory, antiallergic and desensitizing effects. Has an antiexudative effect. Dexamethasone effectively suppresses inflammatory processes.
Combination of glucocorticoid with antibiotics can reduce the risk of infection.
Indications:
Infections of the eye and its appendages:
- Blepharitis.
- Conjunctivitis.
- Keratoconjunctivitis.
- Blepharoconjunctivitis.
- Keratitis.
- Iridocyclitis.
- Prevention of postoperative infectious complications.
Contraindications:
- Individual hypersensitivity to the components of the drug.
- Viral diseases of the eyes (including keratitis caused by Herpes simplex, chicken pox).
- Mycobacterial infection of the eyes.
- Tuberculosis diseases of the eyes.
- Acute herpes zoster.
- Fungal diseases of the eyes.
- Condition after removal of the foreign body of the cornea.
- Purulent infection of the mucous membrane of the eye and eyelids, caused by microorganisms resistant to the action of neomycin.
- Purulent corneal ulcer.
Be wary when:
- Glaucoma.
- Cataract.
Suggested Use:
With a mild infectious process
1-2 drops in the conjunctival sac 4-6 times a day.
In acute severe infectious process
1 to 2 drops in the conjunctival sac every 60 minutes, with a decrease in the frequency of drug installations as the inflammation phenomenon decreases.
Packaging:
- Comes in original packaging. Item is brand new and unopened.
Storage:
- Keep away from direct sunlight.
- Keep locked and away from children.
- Store in dry place at room temperature.
- Do not exceed storage temperature higher than 25 C
Important notice- the outer box design may vary before prior notice!

Cart